Author:
Werner R.A.,Bluemel Christina,Lassmann M.,Kudlich T.,Higuchi T.,Lopci Egesta,Allen-Auerbach M.,Colletti Patrick M.,Rubello Domenico,Zatelli M.C.,Herrmann Ken
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference71 articles.
1. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.;Zaknun;Eur J Nucl Med Mol Imaging,2013
2. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated Cancer Control.;Hodul,2008
3. Carcinoid tumour.;Caplin;Lancet,1998
4. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors.;Ducreux;Am J Gastroenterol,2000
5. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.;Rinke;J Clin Oncol,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献